Back

SCAAR: New generation drug eluting stents are associated with lower stent thrombosis risk in patients with impaired and normal renal function

27 August 2017 (15:35 - 16:25)
Organised by:
Congress Presentation Part of: Long-term outcomes in challenging subjects PCI: long-term outcome ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Robert Edfors

Karolinska Institutet Danderyd Hospital, Stockholm (Sweden)

5 More presentations in this session

Presentation thumbnail
The benefit of complete revascularization in left main percutaneous coronary intervention
Doctor K. Leemasawat (Chiang Mai, TH)
Abstract Slides
Presentation thumbnail
Incidence, determinant and temporal impact of definite stent thrombosis on mortality in women: from the WIN-DES collaborative patient-level pooled analysis
Miss L. Kerkmeijer (Zwolle, NL)
Abstract Slides
Presentation thumbnail
Multivessel PCI versus culprit-vessel only PCI in patients with acute myocardial infarction and multivessel disease.
Doctor B. Vogel (San Diego, US)
Abstract Slides
Presentation thumbnail
Three-year clinical outcomes of the bvs expand registry
Ms C. Felix (Rotterdam, NL)
Abstract
Presentation thumbnail
Independent predictors of the recurrent restenosis after paclitaxel-coated balloon angioplasty for in-stent restenosis
Doctor H. Koiwaya (Miyazaki, JP)
Abstract Slides

Access the full session

Session thumbnail
Long-term outcomes in challenging subjects

The Event

Event poster

ESC Congress 2017

27 August 2017 15:35 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources